Anti-cancer effect of naringin in human lung carcinoma cell line
Abstract
No abstract
References
Bao R, Chan P. Novel compounds in the treatment of lung cancer: Current and developing therapeutic agents. J Exp Pharmacol. 2011: 16: 21-34.
Hanahan D and Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011; 144: 646-74.
Rauf A, Shariati MA, Imran M, Bashir K, Khan SA, Mitra S, Emran TB, Badalova K, Uddin MS, Mubarak MS, Aljohani ASM, Alhumaydhi FA, Derkho M, Korpayev S, Zengin G. Comprehensive review on naringenin and naringin polyphenols as a potent anticancer agent. Environ Sci Pollut Res Int. 2022; 29: 31025-41.
Rogakou EP, Nieves-Neira W, Boon C, Pommier Y, Bonner WM. Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139. J Biol Chem. 2000; 275: 9390-95.
Rubinstein LV, Shoemaker RH, Paull KD, Simon RM, Tosini S, Skehan P, et al. Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines. Natl Cancer Inst. 1990; 82: 111-16.
